Multispecies-compatible antitumor effects of a cross-species small-interfering RNA against mammalian target of rapamycin.

Cellular and Molecular Life Sciences : CMLS
Jeonghyun AhnHeuiran Lee

Abstract

Successful development of sequence-specific siRNA (small interfering RNA)-based drugs requires an siRNA design that functions consistently in different organisms. Utilizing the CAPSID program previously developed by our group, we here designed siRNAs against mammalian target of rapamycin (mTOR) that are entirely complementary among various species and investigated their multispecies-compatible gene-silencing properties. The mTOR siRNAs markedly reduced mTOR expression at both the mRNA and protein levels in human, mouse, and monkey cell lines. The reduction in mTOR expression resulted in inactivation of both mTOR complex I and II signaling pathways, as confirmed by reduced phosphorylation of p70S6K (70-kDa ribosomal protein S6 kinase), 4EBP1 (eIF4E-binding protein 1), and AKT, and nuclear accumulation of FOXO1 (forkhead box O1), with consequent cell-cycle arrest, proliferation inhibition, and autophagy activation. Moreover, interfering with mTOR activity in vivo using mTOR small-hairpin RNA-expressing recombinant adeno-associated virus led to significant antitumor effects in xenograft and allograft models. Thus, the present study demonstrates that cross-species siRNA successfully silences its target and readily produces multispe...Continue Reading

References

May 4, 2004·Nature Reviews. Cancer·Mary-Ann Bjornsti, Peter J Houghton
Aug 18, 2004·Genes & Development·Nissim Hay, Nahum Sonenberg
Apr 12, 2006·Nature Reviews. Genetics·Christophe J Echeverri, Norbert Perrimon
Aug 18, 2006·Nature Reviews. Cancer·David M Sabatini
Jul 20, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mario A Cabrera-SalazarMarco A Passini
Nov 6, 2007·Frontiers in Bioscience : a Journal and Virtual Library·Keerang ParkSung-Ha Cho
Jan 22, 2008·Molecular Cell·Ligang Wu, Joel G Belasco
Jan 17, 2009·Nature Reviews. Genetics·Megha Ghildiyal, Phillip D Zamore
Jan 23, 2009·Nature·Daniela Castanotto, John J Rossi
May 1, 2009·The Biochemical Journal·Juan M García-MartínezDario R Alessi
May 9, 2009·Biochemical and Biophysical Research Communications·Hui Sun LeeHeuiran Lee
Jun 12, 2009·Annals of Surgical Oncology·Yan-Jie ZhangJing-Yuan Fang
Jul 1, 2009·Molecular and Cellular Biology·Lili Shu, Peter J Houghton
Sep 2, 2009·Genetics·Shu KondoNorbert Perrimon
Nov 27, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sandrine M GérantonStephen P Hunt
Jan 15, 2010·Nature Medicine·Matthew R JanesDavid A Fruman
Jul 14, 2010·Current Opinion in Pharmacology·Linda B Couto, Katherine A High
Jul 14, 2010·Drug Discovery Today. Therapeutic Strategies·Qingsong LiuNathanael S Gray
Dec 16, 2010·Nature Reviews. Molecular Cell Biology·Roberto ZoncuDavid M Sabatini
Dec 17, 2010·Nature Reviews. Cancer·Chad V PecotAnil K Sood
Jan 25, 2011·Nature Cell Biology·Joungmok KimKun-Liang Guan
Apr 19, 2011·Nature Reviews. Genetics·Beverly L Davidson, Paul B McCray
Apr 19, 2011·Nature Reviews. Genetics·Federico Mingozzi, Katherine A High

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.